BofA Securities Downgrades Tyra Biosciences (TYRA) to Neutral

BofA Securities analyst Geoff Meacham downgraded Tyra Biosciences (NASDAQ: TYRA) from Buy to Neutral with a price target of $15.00 (from $25.00).

For an analyst ratings summary and ratings history on Tyra Biosciences click here. For more ratings news on Tyra Biosciences click here.

Shares of Tyra Biosciences closed at $14.78 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
• Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities